UPDATE 1-FDA approves Cubist drug to treat acute skin infections

June 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved a new drug to treat acute bacterial skin infections made by Cubist Pharmaceuticals Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.